Response to Comment on “Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer”
Authors:
- 1 June 2013
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 190 (11) , 5341-5342
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Highlights of 10 years of immunology in Nature Reviews ImmunologyNature Reviews Immunology, 2011
- Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cellsNature Immunology, 2011
- The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer CellsPLOS ONE, 2011
- Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulatorsBlood, 2011
- Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?Nature Reviews Cancer, 2009
- Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer diseaseAmino Acids, 2008